High expression of LDHC has been associated with poor clinical outcome in the majority of cancer types, and favorable prognosis in a select few cancers such as head and neck squamous cell carcinoma (HNSC) and cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC). Here, LDHC is linked to cancer.